The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Automated Insulin Delivery Systems-Global Market Insights and Sales Trends 2025
Synopsis
The global Automated Insulin Delivery Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Automated Insulin Delivery Systems in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Diabetes Clinics,, are propelling Automated Insulin Delivery Systems market. Type I Diabetes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Type II Diabetes segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Automated Insulin Delivery Systems market, driven by demand from China, the second largest economy with some signs of stabilising, the Automated Insulin Delivery Systems market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Automated Insulin Delivery Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Automated Insulin Delivery Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Automated Insulin Delivery Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Automated Insulin Delivery Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Automated Insulin Delivery Systems covered in this report include Eli Lily, Tandem, Insulet and Big Foot Biomedical, etc.
The global Automated Insulin Delivery Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lily
Tandem
Insulet
Big Foot Biomedical
Global Automated Insulin Delivery Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Automated Insulin Delivery Systems market, Segment by Type:
Type I Diabetes
Type II Diabetes
Global Automated Insulin Delivery Systems market, by Application
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Automated Insulin Delivery Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Automated Insulin Delivery Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Automated Insulin Delivery Systems in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Diabetes Clinics,, are propelling Automated Insulin Delivery Systems market. Type I Diabetes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Type II Diabetes segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Automated Insulin Delivery Systems market, driven by demand from China, the second largest economy with some signs of stabilising, the Automated Insulin Delivery Systems market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Automated Insulin Delivery Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Automated Insulin Delivery Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Automated Insulin Delivery Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Automated Insulin Delivery Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Automated Insulin Delivery Systems covered in this report include Eli Lily, Tandem, Insulet and Big Foot Biomedical, etc.
The global Automated Insulin Delivery Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lily
Tandem
Insulet
Big Foot Biomedical
Global Automated Insulin Delivery Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Automated Insulin Delivery Systems market, Segment by Type:
Type I Diabetes
Type II Diabetes
Global Automated Insulin Delivery Systems market, by Application
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Automated Insulin Delivery Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Automated Insulin Delivery Systems
1.1 Automated Insulin Delivery Systems Market Overview
1.1.1 Automated Insulin Delivery Systems Product Scope
1.1.2 Automated Insulin Delivery Systems Market Status and Outlook
1.2 Global Automated Insulin Delivery Systems Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Automated Insulin Delivery Systems Market Size by Region (2018-2029)
1.4 Global Automated Insulin Delivery Systems Historic Market Size by Region (2018-2023)
1.5 Global Automated Insulin Delivery Systems Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Automated Insulin Delivery Systems Market Size (2018-2029)
1.6.1 North America Automated Insulin Delivery Systems Market Size (2018-2029)
1.6.2 Europe Automated Insulin Delivery Systems Market Size (2018-2029)
1.6.3 Asia-Pacific Automated Insulin Delivery Systems Market Size (2018-2029)
1.6.4 Latin America Automated Insulin Delivery Systems Market Size (2018-2029)
1.6.5 Middle East & Africa Automated Insulin Delivery Systems Market Size (2018-2029)
2 Automated Insulin Delivery Systems Market by Type
2.1 Introduction
2.1.1 Type I Diabetes
2.1.2 Type II Diabetes
2.2 Global Automated Insulin Delivery Systems Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Automated Insulin Delivery Systems Historic Market Size by Type (2018-2023)
2.2.2 Global Automated Insulin Delivery Systems Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Automated Insulin Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Automated Insulin Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Automated Insulin Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Automated Insulin Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Automated Insulin Delivery Systems Revenue Breakdown by Type (2018-2029)
3 Automated Insulin Delivery Systems Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Diabetes Clinics
3.2 Global Automated Insulin Delivery Systems Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Automated Insulin Delivery Systems Historic Market Size by Application (2018-2023)
3.2.2 Global Automated Insulin Delivery Systems Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Automated Insulin Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Automated Insulin Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Automated Insulin Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Automated Insulin Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Automated Insulin Delivery Systems Revenue Breakdown by Application (2018-2029)
4 Automated Insulin Delivery Systems Competition Analysis by Players
4.1 Global Automated Insulin Delivery Systems Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Automated Insulin Delivery Systems as of 2022)
4.3 Date of Key Players Enter into Automated Insulin Delivery Systems Market
4.4 Global Top Players Automated Insulin Delivery Systems Headquarters and Area Served
4.5 Key Players Automated Insulin Delivery Systems Product Solution and Service
4.6 Competitive Status
4.6.1 Automated Insulin Delivery Systems Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eli Lily
5.1.1 Eli Lily Profile
5.1.2 Eli Lily Main Business
5.1.3 Eli Lily Automated Insulin Delivery Systems Products, Services and Solutions
5.1.4 Eli Lily Automated Insulin Delivery Systems Revenue (US$ Million) & (2018-2023)
5.1.5 Eli Lily Recent Developments
5.2 Tandem
5.2.1 Tandem Profile
5.2.2 Tandem Main Business
5.2.3 Tandem Automated Insulin Delivery Systems Products, Services and Solutions
5.2.4 Tandem Automated Insulin Delivery Systems Revenue (US$ Million) & (2018-2023)
5.2.5 Tandem Recent Developments
5.3 Insulet
5.3.1 Insulet Profile
5.3.2 Insulet Main Business
5.3.3 Insulet Automated Insulin Delivery Systems Products, Services and Solutions
5.3.4 Insulet Automated Insulin Delivery Systems Revenue (US$ Million) & (2018-2023)
5.3.5 Big Foot Biomedical Recent Developments
5.4 Big Foot Biomedical
5.4.1 Big Foot Biomedical Profile
5.4.2 Big Foot Biomedical Main Business
5.4.3 Big Foot Biomedical Automated Insulin Delivery Systems Products, Services and Solutions
5.4.4 Big Foot Biomedical Automated Insulin Delivery Systems Revenue (US$ Million) & (2018-2023)
5.4.5 Big Foot Biomedical Recent Developments
6 North America
6.1 North America Automated Insulin Delivery Systems Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Automated Insulin Delivery Systems Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Automated Insulin Delivery Systems Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Automated Insulin Delivery Systems Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Automated Insulin Delivery Systems Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Automated Insulin Delivery Systems Market Dynamics
11.1 Automated Insulin Delivery Systems Industry Trends
11.2 Automated Insulin Delivery Systems Market Drivers
11.3 Automated Insulin Delivery Systems Market Challenges
11.4 Automated Insulin Delivery Systems Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
